6 December 2024
Meet Us Online at the 3rd International Electronic Conference on Biomedicines, 12–15 May 2025
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Conference: 3rd International Electronic Conference on Biomedicines
Time: 12–15 May 2025, CEST, Online
Website: https://sciforum.net/event/ECB2025
We cordially invite you to attend the above event organized by the MDPI journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9). The conference will take place virtually on 12–15 May 2025, CEST.
Conference Chairs:
The Topics of Interest:
S1. Insulin resistance or hyperinsulinemia;
S2. Immunotherapy and adverse effects;
S3. Tumor microenvironment;
S4. Immune system, tumor immunology, and autoimmune disease;
S5. Biomedicine in cardiovascular diseases;
S6. Diabetes, obesity and metabolic diseases;
S7. Gene therapy and gene editing;
S8. Rare diseases;
S9. Molecular mechanisms of neurodegeneration.
Important Dates:
Deadline for abstract submission: 19 January 2025;
Notification of acceptance: 19 February 2025;
Deadline for free registration: 8 May 2025.
Submit your abstract here.
Register for the conference here.
For any inquiries regarding the event, please contact ecb@mdpi.com. We look forward to seeing you at ECB2025.